1. Home
  2. DNLI vs ARLO Comparison

DNLI vs ARLO Comparison

Compare DNLI & ARLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • ARLO
  • Stock Information
  • Founded
  • DNLI 2013
  • ARLO 2018
  • Country
  • DNLI United States
  • ARLO United States
  • Employees
  • DNLI N/A
  • ARLO N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • ARLO Consumer Electronics/Appliances
  • Sector
  • DNLI Health Care
  • ARLO Consumer Staples
  • Exchange
  • DNLI Nasdaq
  • ARLO Nasdaq
  • Market Cap
  • DNLI 2.2B
  • ARLO 2.0B
  • IPO Year
  • DNLI 2017
  • ARLO 2018
  • Fundamental
  • Price
  • DNLI $14.93
  • ARLO $17.78
  • Analyst Decision
  • DNLI Strong Buy
  • ARLO Strong Buy
  • Analyst Count
  • DNLI 13
  • ARLO 2
  • Target Price
  • DNLI $32.64
  • ARLO $24.00
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • ARLO 907.7K
  • Earning Date
  • DNLI 11-03-2025
  • ARLO 11-06-2025
  • Dividend Yield
  • DNLI N/A
  • ARLO N/A
  • EPS Growth
  • DNLI N/A
  • ARLO N/A
  • EPS
  • DNLI N/A
  • ARLO N/A
  • Revenue
  • DNLI N/A
  • ARLO $507,710,000.00
  • Revenue This Year
  • DNLI N/A
  • ARLO $4.65
  • Revenue Next Year
  • DNLI $94,232.03
  • ARLO $7.87
  • P/E Ratio
  • DNLI N/A
  • ARLO N/A
  • Revenue Growth
  • DNLI N/A
  • ARLO N/A
  • 52 Week Low
  • DNLI $10.57
  • ARLO $7.84
  • 52 Week High
  • DNLI $33.33
  • ARLO $19.94
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.86
  • ARLO 45.77
  • Support Level
  • DNLI $15.53
  • ARLO $18.74
  • Resistance Level
  • DNLI $17.02
  • ARLO $19.94
  • Average True Range (ATR)
  • DNLI 0.79
  • ARLO 0.68
  • MACD
  • DNLI -0.19
  • ARLO -0.01
  • Stochastic Oscillator
  • DNLI 0.71
  • ARLO 20.45

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About ARLO Arlo Technologies Inc.

Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. It combines a cloud infrastructure and mobile app with various smart connected devices to provide users with visibility, insight, and a means to help protect and connect in real-time with the people and things from any location with a Wi-Fi or a cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.

Share on Social Networks: